Immune or idiopathic thrombocytopenic purpura (ITP) in childhood: What are the risks and who should be treated?

Journal of Pediatrics

Volumn 143, Issue 3, 2003, Pages 287-289

  De Alarcon, Pedro A ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; IMMUNOGLOBULIN; RHESUS D ANTIBODY;

BLEEDING; BLOOD TRANSFUSION; BRAIN HEMORRHAGE; CHILDHOOD; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; INCIDENCE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; TREATMENT OUTCOME; UNITED STATES;

EID: 0141727748     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/S0022-3476(03)00360-3     Document Type: Editorial

References (21)

1. Rosthøj S, Hundlund-Treutiger I, Zeller B, Jonsson OG, Wesenberg FH. Duration and morbidity of newly diagnosed idiopathic thrombocytopenic purpura in children: a prospective Nordic study of an unselected cohort. J Pediatr 2003;143:302-7.
2. McClure PD. Idiopathic thrornbocytopenic purpura in children: should corticosteroids be given? Am J Dis Child 1977;131:357-9.
3. Lusher JM, Iyer R. Idiopathic thrombocytopenic purpura in children. Semin Thromb Hemost 1977;3:175-99.
4. Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, Morell A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228-31.
5. Salama A, Mueller-Eckhardt C, Kiefel V. Effect of intravenous immunoglobulin in immune thrombocytopenia. Lancet 1983;2:193-5.
6. Buchanan GR. The nontreatment of childhood idiopathic thrombocytopenic purpura. Eur J Pediatr 1987;146:107-12.
7. Tarantino MD. On the conservative management of acute immune thrombocytopenia in children. J Pediatr 2001;138:787-8.
8. Eden OB, Lilleyman JS. Guidelines for management of idiopathic thrombocytopenic purpura. The British Paediatric Haematology Group. Arch Dis Child 1992;67:1056-8.
9. Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children, and in pregnancy. Br J Haematol 2003;120:574-96.
10. George JN, Woolf SH, Raskob GE, Wasser JS, Aledort LM, Ballem PJ, et al. Idiopathic thrombocytopenic purpura: a practice guideline developed by explicit methods for the American Society of Hematology [review]. Blood 1996;88:3-40.
11. Sutor AH, Harms A, Kaufmehl K. Acute immune thrombocytopenia (ITP) in childhood: retrospective and prospective survey in Germany. Semin Thromb Hemost 2001;27:253-67.
12. Bolton-Maggs PH, Moon I. Assessment of UK practice for management of acute childhood idiopathic thrombocytopenic purpura against punished guidelines. Lancet 1997;350:620-3.
13. Vesely SK, Buchanan GR, Adix L, George JN, Cohen AR, Blanchette VS, et al. Self-reported initial management of childhood idiopathic thrombocytopenic purpura: results of a survey of members of the American Society of Pediatric Hematology/Oncology, 2001. J Pediatr Hematol Oncol 2003;25:130-3.
14. Imbach P, Wagner HP, Berchtold W, Gaedicke G, Hirt A, Joller P, et al. Intravenous immunoglobulin versus oral corticosteroids in acute immune thrombocytopenic purpura in childhood. Lancet 1985;2:464-8.
15. Kuhne T, Imbach P, Bolton-Maggs PH, Berchtold W, Blanchette V, Buchanan GR. Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study. Lancet 2001;358:2122-5.
16. Woerner SJ, Abildgaard CF, French BN. Intracranial hemorrhage in children with idiopathic thrombocytopenic purpura. Pediatrics 1981;67:453-460.
17. Medeiros D, Buchanan GR. Major hemorrhage in children with idiopathic thrombocytopenic purpura - immediate response to therapy and long-term outcome. J Pediatr 1998;133:334-9.
18. Blanchette VS, Turner C. Treatment of acute idiopathic thrombocytopenic purpura. J Pediatr 1986;108:326-7.
19. Blanchette VS, Luke B, Andrew M, Sommerville-Nielsen S, Barnard D, de Veber B, et al. A prospective, randomized trial of high-dose intravenous immune globulin G therapy, oral prednisone therapy, and no therapy in childhood acute immune thrombocytopenic purpura. J Pediatr 1993;123:989-995.
20. Dickerhoff R, Von Ruecker A. The clinical course of immune thrombocytopenic purpura in children who did not receive intravenous immunoglobulins or sustained prednisone treatment. J Pediatr 2000;137:629-32.
21. Mori PG, Lanza T, Mancuso G, de Mattia D, Catera P, Miano C, et al. Treatment of acute idiopathic thrombocytopenic purpura (AITP): cooperative Italian study group results. Pediatr Hematol Oncol 1988;5:169-178.